A61K31/045

COMPOSITIONS INCLUDING TERPENES, CANNABINOID OILS, OR FLAVONOIDS AND USES THEREOF
20230165807 · 2023-06-01 ·

Provided herein are compositions including terpenes, cannabinoid oils, or flavonoids, or a combination thereof and uses thereof.

COMPOSITIONS INCLUDING TERPENES, CANNABINOID OILS, OR FLAVONOIDS AND USES THEREOF
20230165807 · 2023-06-01 ·

Provided herein are compositions including terpenes, cannabinoid oils, or flavonoids, or a combination thereof and uses thereof.

USE OF DANDELION AND MONOMER COMPOUNDS THEREOF FOR KILLING MITES
20230165921 · 2023-06-01 ·

Use of dandelion and monomer compounds thereof for preparing products for killing mites. Dandelion can reduce the survival time of mites. The dandelion monomers, especially taraxerol, diosmetin and taraxasterol acetate, can significantly shorten the survival time of demodex, and can be used for preparing products for killing and inhibiting mites.

USE OF DANDELION AND MONOMER COMPOUNDS THEREOF FOR KILLING MITES
20230165921 · 2023-06-01 ·

Use of dandelion and monomer compounds thereof for preparing products for killing mites. Dandelion can reduce the survival time of mites. The dandelion monomers, especially taraxerol, diosmetin and taraxasterol acetate, can significantly shorten the survival time of demodex, and can be used for preparing products for killing and inhibiting mites.

PKC-ACTIVATING COMPOUNDS FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES
20220356161 · 2022-11-10 · ·

The present invention relates to methods of activate an isoform of protein kinase C (PKC) for the treatment of neurological diseases including Alzheimer's disease and stroke using cyclopropanated or epoxidized derivatives of mono- and polyunsaturated fatty acids. The present invention also relates to methods of reducing neurodegeneration using cyclopropanated or epoxidized derivatives of mono- and polyunsaturated fatty acids.

PKC-ACTIVATING COMPOUNDS FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES
20220356161 · 2022-11-10 · ·

The present invention relates to methods of activate an isoform of protein kinase C (PKC) for the treatment of neurological diseases including Alzheimer's disease and stroke using cyclopropanated or epoxidized derivatives of mono- and polyunsaturated fatty acids. The present invention also relates to methods of reducing neurodegeneration using cyclopropanated or epoxidized derivatives of mono- and polyunsaturated fatty acids.

Throat solution for treatment of cold, flu and sore throat
20170326123 · 2017-11-16 ·

A composition of isopropyl or ethyl alcohol, Cetylpyridinium Chloride and essential oils that enable the composition to have a prolonged antimicrobial effect by reducing the normal rate of alcohol dehydration, reducing toxicity and increasing duration of efficacy with proper application to oral cavity, oropharynx and directly pharyngeal tonsils.

Throat solution for treatment of cold, flu and sore throat
20170326123 · 2017-11-16 ·

A composition of isopropyl or ethyl alcohol, Cetylpyridinium Chloride and essential oils that enable the composition to have a prolonged antimicrobial effect by reducing the normal rate of alcohol dehydration, reducing toxicity and increasing duration of efficacy with proper application to oral cavity, oropharynx and directly pharyngeal tonsils.

Throat solution for treatment of cold, flu and sore throat
20170326123 · 2017-11-16 ·

A composition of isopropyl or ethyl alcohol, Cetylpyridinium Chloride and essential oils that enable the composition to have a prolonged antimicrobial effect by reducing the normal rate of alcohol dehydration, reducing toxicity and increasing duration of efficacy with proper application to oral cavity, oropharynx and directly pharyngeal tonsils.

Membrane layers for analyte sensors

Disclosed are devices for determining an analyte concentration (e.g., glucose). The devices comprise a sensor configured to generate a signal associated with a concentration of an analyte and a sensing membrane located over the sensor. The sensing membrane comprises a biointerface layer which interfaces with a biological fluid containing the analyte to be measured. The biointerface layer can comprises a biointerface polymer, wherein the biointerface polymer comprises polyurethane and/or polyurea segments and one or more zwitterionic repeating units. The sensing membrane can also comprise an enzyme layer, wherein the enzyme layer comprises an enzyme and a polymer comprising polyurethane and/or polyurea segments and one or more zwitterionic repeating units. The sensing membrane can also comprise a diffusion-resistance layer, which can comprise a base polymer having a lowest Tg of greater than −50 C.